Latest Insights on GOOG
Don’t Drink the Tesla Kool-Aid — Here’s a Smarter Buy February 7, 2020 American Investor Today, Stocks Tesla shares surged to nearly $1,000 on Tuesday. But the carmaker’s rally is a sign of euphoria for growth stocks. And that’s bad news for future returns. Anthony Planas tells you why you need to park your money in a forgotten sector.
Amazon’s $1 Trillion Playbook: How to Buy the Next Market Disruptor February 6, 2020 American Investor Today, Trading Strategies Today, Amazon and Netflix are known as industry disruptors. But in their early days, they were considered underdogs going up against giant brick-and-mortar retail chains. Today, Charles Mizrahi uncovers the one secret that underpins “underdogs” such as Netflix and Amazon. 
The Chinese Time Bomb; Tesla Tendies Time February 4, 2020 Great Stuff The Ticking Chinese Time Bomb Sorry to ruin your bull market party, but there’s an issue we need to discuss … like, right now. I’m talking about the Wuhan coronavirus and the U.S.-China “phase 1” trade deal. Here’s the thing: More than 20,000 Chinese are infected with the Wuhan virus, with some 427 dead. Tens […]
The Wuhan Virus Is Pushing These Stocks Higher February 4, 2020 Big Picture. Big Profits., Global Economy, Investment Opportunities, News [4-minute read] Don’t miss out on one of the best opportunities to ever come from this massive economy.
Profit From AbbVie’s Struggles Today February 4, 2020 American Investor Today, Stocks Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.MEET OUR EXPERTS
Chief Strategist of Strategic Fortunes and three elite services
Director of VIP Services
Founder of TRADEMONSTER.ai
Founder of Weekend Trader
Chief Investment Strategist of Money & Markets
Research Analyst
